Kimberly Manhard - 03 Jun 2026 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Reporting relationship: Director
Issuer ticker: INBX
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 17:28:48 UTC
Prior SEC filing: 29 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Kelly D. Deck, as attorney-in-fact for Kimberly Manhard

Key filing fact

Kimberly Manhard filed Form 4 for Inhibrx Biosciences, Inc. (INBX) on 04 Jun 2026.

Key facts

This page summarizes Kimberly Manhard's Form 4 filing for Inhibrx Biosciences, Inc. (INBX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 17:28.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001202094 Primary reporting owner

Relationship: Director
Address: C/O INHIBRX BIOSCIENCES, INC., 11025 NORTH TORREY PINES ROAD, SUITE 140, LA JOLLA
Signature: /s/ Kelly D. Deck, as attorney-in-fact for Kimberly Manhard
Signature date: 04 Jun 2026

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INBX transaction Derivative

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date.